ActivePassive國際股票主動型ETF APIE 深 滬
已收盤 02-06 16:00:00 美东时间
38.07
+0.902
+2.43%
華盛通- 最 高38.08
- 今 開37.76
- 成交量 4.75万股
- 最 低 37.76
- 昨 收 37.168
- 總市值 10.09亿
- 52周最高 38.28
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 24.8615
- 委 比 0.00%
- 總股本 2650.00万
- 歷史最高 38.28
- 量 比 0.86
- 振 幅 0.86%
- 歷史最低 21.1363
- 每 手 1
- 風險率 2.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Repertoire Immune Medicines Announces Strategic Collaboration With Lilly Worth Up To $1.93 Bln
BRIEF-Repertoire Immune Medicines Announces Strategic Collaboration With Lilly Worth Up To $1.93 Bln Jan 29 (Reuters) - Repertoire Immune Medicines: REPERTOIRE IMMUNE MEDICINES: TO GET $85 MILLION UPFRONT, $1.84 BILLION IN MILESTONE PAYMENTS REPERTOIRE IMMUNE MEDICINES ANNOUNCES STRATEGIC COLLABORAT
01-29 19:30
BRIEF-Arsenalbio And Bristol Myers Squibb Achieve Milestone For AB-4000 Series
Jan 13 (Reuters) - Bristol-Myers Squibb Co BMY.N: ARSENALBIO AND BRISTOL MYERS SQUIBB ACHIEVE MILESTONE FOR AB-4000 SERIES AS PART OF ONGOING MULTI-PROGRAM COLLABORATION TO ADVANCE NEXT-GENERATION T C...
2025-01-13 21:42
BRIEF-Cartesian Therapeutics Highlights Progress And 2025 Strategic Priorities
Jan 13 (Reuters) - Cartesian Therapeutics Inc RNAC.O: CARTESIAN THERAPEUTICS HIGHLIGHTS PROGRESS AND 2025 STRATEGIC PRIORITIES ACROSS PIPELINE OF MRNA CELL THERAPIES FOR AUTOIMMUNE DISEASES CASH RESOU...
2025-01-13 21:39
BRIEF-Johnson & Johnson To Acquire Intra-Cellular Therapies for $14.6 billion
Jan 13 (Reuters) - Johnson & Johnson JNJ.N: JOHNSON & JOHNSON STRENGTHENS NEUROSCIENCE LEADERSHIP WITH ACQUISITION OF INTRA-CELLULAR THERAPIES, INC. JOHNSON & JOHNSON - DEAL VALUED AT $14.6 BILLION, $...
2025-01-13 19:50
BRIEF-Normunity Closes $75 Million Series B Financing To Advance Lead Drug Program
Jan 13 (Reuters) - Pfizer Inc PFE.N: NORMUNITY CLOSES $75 MILLION SERIES B FINANCING TO ADVANCE LEAD DRUG PROGRAM INTO THE CLINIC AND BROADEN PIPELINE OF NOVEL ANTI-CANCER THERAPIES TARGETING UNTAPPED...
2025-01-13 19:24
BRIEF-Johnson & Johnson Is Exploring Bid For Intra-Cellular Therapies - Bloomberg News
Jan 12 (Reuters) - Johnson & Johnson JNJ.N: JOHNSON & JOHNSON IS EXPLORING BID FOR INTRA-CELLULAR THERAPIES - BLOOMBERG NEWS Source text: https://tinyurl.com/2ewjs83p Further company coverage: JNJ.N (...
2025-01-13 05:29
BRIEF-Cintas Makes $5.1 Billion Takeover Offer For Uniform Supplier Unifirst- WSJ
Jan 7 (Reuters) - CINTAS MAKES $5.1 BILLION TAKEOVER OFFER FOR UNIFORM SUPPLIER UNIFIRST- WSJ CINTAS PROPOSED ACQUIRING ALL OF UNIFIRST’S OUTSTANDING COMMON AND CLASS B SHARES FOR $275 APIECE, IN CASH...
2025-01-07 21:03
Why UK's National Grid Shares Are Diving Today
National Grid plc's shares down after reporting lower FY24 revenue, with 32% increase in EPS. Plans to invest $75 billion in US and UK over 5 years.
2024-05-24 01:39
